A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Transgene
Actym Therapeutics, Inc.
Young Adult Survivors United
Eli Lilly and Company
Washington University School of Medicine
Elevation Oncology
Washington University School of Medicine
pharmaand GmbH
NBE-Therapeutics AG
Pfizer
Roswell Park Cancer Institute
Nektar Therapeutics
MacroGenics
Seagen Inc.
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
National Institutes of Health Clinical Center (CC)
Yale University
CureOne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Western Regional Medical Center
University Health Network, Toronto
Masonic Cancer Center, University of Minnesota
Pfizer
Emory University
Case Comprehensive Cancer Center